Mainga Hamaluba/PLoS Med
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.Schilling WHK
Mukaka M
Callery JJ
Llewelyn MJ
Cruz CV
Dhorda M
Ngernseng T
Waithira N
Ekkapongpisit M
Watson JA
Chandna A
Nelwan EJ
Hamers RL
Etyang A
Beg MA
Sow S
Yavo W
Allabi AC
Basnyat B
Sharma SK
Amofa-Sekyi M
Yonga P
Adler A
Yuentrakul P
Cope T
Thaipadungpanit J
Rienpradub P
Imwong M
Abdad MY
Blacksell SD
Tarning J
Goudjo FF
Dossou AD
Konate-Toure A
Assi SB
Ouffoue K
Nasronudin N
Rachman BE
Romadhon PZ
Dewanto DD
Heryana MO
Novi T
Pasaribu AP
Mutiara M
Nasution MPR
Khairunnisa K
Dalimunthe FA
Airlangga E
Fahrezzy A
Subronto Y
Ananda NR
Rahardjani M
Rimainar A
Lucinde RK
Timbwa M
Onyango OE
Agutu C
Akech S
Hamaluba M
Kipyego J
Ngachi O
Haidara FC
Traore OY
Diarra F
Khanal B
Dahal P
Shrestha S
Rijal S
Kabore Y
Adehossi E
Guindo O
Qamar FN
Kazi AM
Woodrow CJ
Laird S
Cheeba M
Ayles H
Cheah PY
Taylor WRJ
Batty EM
Chotivanich K
Pukrittayakamee S
Phumratanaprapin W
von Seidlein L
Dondorp A
Day NPJ
White NJ
Copcov Collaborative Group
PLoS Med, (2024). 21:e1004428
